Eight of the 30 Dow components lost value in 2024. Here's a quick look at each company, to help you determine which dividend ...

Eli Lilly's diverse portfolio shows broad growth, with significant contributions from oncology and other therapeutic areas.

As the United States stock market experiences a surge, with major indices like the S&P 500 and Dow Jones Industrial Average posting their best weekly gains in months, investors are keenly eyeing ...

Everything to Know about Macro and Markets Stocks surged, clocking in their best week since the November presidential ...

Sales of Eli Lilly's lead drug, tirzepatide, which it markets as Zepbound for weight loss and Mounjaro for diabetes, leapt up to a combined $5.4 billion in the fourth quarter. That's some amazing ...

Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December ...

Wall Street stocks were in the green at the close of trading on Friday as traders prepped for a three-day break.

On the macro front, building permits decreased by 0.7% month-on-month in December to a seasonally adjusted rate of 1.48m, ...

Investors scored big wins last year as the S&P 500, the Nasdaq, and the Dow Jones Industrial Average all climbed by double ...

There's still a lot to like about Eli Lilly stock, an analyst said Wednesday after the weight-loss drugs kingpin cut its ...

The Dow Jones Industrial Average rose by 804 points, or 1.9%, while the S&P 500 gained 2% and the Nasdaq Composite climbed ...

World stocks are mixed follow Wall Street’s mostly positive performance ahead of key U.S. inflation data that could influence ...